EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript May 6, 2026
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.99 EPS, expectations were $-0.79.
Operator: Good morning. My name is Brittany, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint First Quarter 2026 Financial Results and Recent Corporate Development Conference Call. [Operator Instructions] Please be advised that...
